Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Clonal hematopoiesis of indeterminate potential and type 2 diabetes mellitus among patients with STEMI: from a prospective cohort study combing bidirectional Mendelian randomization

Fig. 2

The frequency of clonal haematopoiesis of indeterminate potential mutations (variant allele fraction ≥ 2.0%) in non-T2DM subjects versus patients with T2DM according to A age. Additionally, we analyzed the occurrence of specific types of CHIP mutations among surviving subjects versus patients succumbing to various causes of mortality across the entire enrolled cohort (B), the T2DM subgroup (C), and the non-T2DM demographic (D). T2DM type 2 diabetes mellitus; CHIP clonal haematopoiesis of indeterminate potential; VAF variant allele fraction

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840